Introduction
Packaging of DNA into a compact structure, to control gene transcription, and to protect DNA from damage are among the most relevant functions of chromatin in eukaryotic cells. Chromatin that is structurally loose allows gene transcription (euchromatin), whereas highly condensed chromatin (heterochromatin) is generally associated with repression of gene transcription and genome stability. Specifically, chromatin is composed of nucleosomes that are comprised of two copies of each of H2A, H2B, H3, and H4, and these structures are compacted into chromatin by linker histones such as H1. Epigenetic control of cell behaviour, defined as the process whereby gene expression is regulated by heritable mechanisms that do not affect DNA sequence, can affect cell growth and differentiation and impact on the pathophysiology of chronic and acute diseases. Several epigenetic mechanisms regulate the stability Abstract In eukaryote cells, chromatin appears in several forms and is composed of genomic DNA, protein and RNA. The protein content of chromatin is composed primarily of core histones that are packaged into nucleosomes resulting in the condensation of the DNA. Several epigenetic mechanisms regulate the stability of the nucleosomes and the protein-protein interactions that modify the transcriptional activity of the DNA. Interestingly, epigenetic control of gene expression has recently emerged as a relevant mechanism involved in the regulation of many different biological processes including that of muscle development, muscle mass maintenance, function, and phenotype in health and disease. Recent investigations have shed light into the epigenetic control of biological mechanisms that are key regulators of embryonic muscle development and postnatal myogenesis. In the present review article, we provide a summary of the contents discussed in session 08, titled "Epigenetics of muscle regeneration", during the 1 3 of the nucleosomes and the protein-protein interactions that modify the transcriptional activity of the DNA (Baar 2010) . A few examples of epigenetic modifications include: (1) non-coding RNAs including microRNAs, (2) histone acetylation and deacetylation, (3) histone methylation, and (4) DNA methylation. Interestingly, epigenetic control of gene expression has recently emerged as a relevant mechanism involved in the regulation of many different biological processes including that of muscle mass, function, and phenotype in health and disease (Donaldson et al. 2013; Lewis et al. 2012; Puig-Vilanova et al. 2014a , b, 2015 . In the present review we summarize the contents discussed in the "Epigenetics of muscle regeneration" session at the 45th European Muscle Conference. The main theme of that session was to highlight the most recent progress on the role of epigenetics in the regulation of the process of muscle regeneration. As such, the current mini-review has been divided into two major sections: (1) a brief introduction on the topic of muscle development and postnatal myogenesis; and (2) the most relevant epigenetic players that control muscle development and regeneration.
Muscle development
During embryonic myogenesis, paraxial mesoderm derived cells generate the first primary muscle fibers of the body that act as a scaffold for the formation of secondary fibers. The latter appear during foetal development and they continue to grow by nuclear accretion until perinatal stages (Comai and Tajbakhsh 2014) . A reservoir of myogenic cells is subsequently allocated during the perinatal period and it will give rise to the satellite (stem) cells. The privileged position of these cells on the surface of the myofiber, beneath the basal lamina, enables them to respond to mechanical, structural, and functional stimuli of skeletal muscle fibers. During the early juvenile growth phase, satellite cells proliferate and add nuclei to the growing myofibers; subsequently, proliferation declines gradually as myofibers increase in diameter (Moss and Leblond 1971; White et al. 2010) . In adult muscles, satellite cells remain quiescent until muscle injury triggers their activation (Snow 1978; Yablonka-Reuveni 1995) . Despite certain differences such as the lack of a primary myogenesis wave (Tajbakhsh 2009 ), prenatal and postnatal myogenesis share some molecular and functional similarities including the sequential appearance of transcription factors from an upstream state (ex. Pax7, Myf5) to a committed and differentiated state (ex. MyoD, Myogenin) (Parker et al. 2003) . Small injuries, such as those promoted by daily life activities, lead to minimal proliferation, whereas major lesions induce longer proliferation periods before differentiation may take place (Yablonka-Reuveni 2011). Signals from the muscle niche, microvasculture, local inflammation (Yablonka-Reuveni 2011) and systemic factors activate satellite cells (Carlson et al. 2009; Conboy et al. 2005) .
In response to muscle injury, satellite cells contribute to repair of damaged fibers while new myofibers are also formed following a program of cell division and fusion of myoblasts (Yablonka-Reuveni et al. 2008) . A number of regulatory factors control satellite cell behaviour from quiescence, entry into proliferation, maintenance of the cell cycle, differentiation, and subsequent self-renewal following return to homeostasis (Yablonka-Reuveni et al. 2008 ) (Collins et al. 2005; Sacco et al. 2008) . It has been estimated that during early postnatal growth, satellite cells represent 30% of the nuclei, while they only constitute 2-7% of nuclei in healthy adult skeletal muscles (Halevy et al. 2004; Hawke and Garry 2001) . The numbers of satellite cells were also reported to decline with age in healthy elderly subjects (Collins et al. 2007; Shefer et al. 2006) .
The basic helix-loop-helix transcription factor MyoD plays a key role in muscle determination and differentiation, and it is one of the earliest markers of myogenic commitment. Notably, seminal experiments demonstrated that MyoD can transform a variety of cell types, including fibroblasts, into myoblasts that will subsequently fuse to form myotubes (Davis et al. 1987) . In quiescent satellite cells that are characterized by the expression of Pax7, MyoD protein is generally not detectable. Following their activation, MyoD transcription and protein levels increase dramatically (Comai and Tajbakhsh 2014) . As a transcription factor, MyoD binds to enhancers and promoters to regulate myogenesis, and it was shown to activate muscle genes in a variety of differentiated cell lines from several species (chicken, human, and rat) (Weintraub et al. 1989 ). Myf5 and Mrf4 also act as determination genes, whereas Myogenin is a differentiation factor-and each of these factors that belong to the MyoD family have unique and overlapping properties as well as expression patterns during embryogenesis (Comai and Tajbakhsh 2014) .
Early striated muscle development arising from somites in the trunk is the result of the action of the paired-homeobox transcription factors Pax3 and Pax7 genes. Importantly, genetic ablation of the Pax3 lineage was embryonically lethal and prevented the emergence of Pax7-positive cells, while ablation of Pax7-expressing cells resulted in the appearance of smaller muscles with fewer myofibers in the limbs at birth (Hutcheson et al. 2009; Seale et al. 2000) . Pax3 is a key factor in the regulation of myogenesis for skeletal muscles in the trunk and limbs where some downstream targets include MyoD and the tyrosine kinase receptor c-met. Although its expression is not restricted to skeletal muscle, Pax3 is expressed well before the onset of myogenesis, in presomitic mesoderm, and subsequently its expression is restricted to the epithelial dermomyotome of the somite that gives rise to multiple cell types including all of the myogenic cells of the trunk and limbs. Notably, Pax3 is not expressed in head derived muscle progenitors. In this case, Tbx1 and Pitx2, among other transcription factors, play critical roles in establishing myogenesis from cranial mesoderm (Comai and Tajbakhsh 2014) .
Epigenetic regulation of myogenesis/muscle development
Epigenetic events regulate the quiescent and proliferation states of muscle satellite cells and their progeny. In this context, DNA methylation is a major repressive mechanism of muscle satellite cell differentiation (Palacios and Puri 2006; Bigot et al. 2015) , whereas demethylation along with MyoD and Myogenin are required for the initiation of the differentiation program (Palacios and Puri 2006) . Mechanisms that act on chromatin-associated histones are also involved in the control of muscle satellite cell quiescence and proliferation. Histone acetylation is a transient, enzymatically controlled biochemical process, and the most common posttranslational modification of histone proteins. The acetyl group from acetyl-CoA is transferred to a lysine residue, thus converting its basic side chain into a neutral residue thereby resulting in an open chromatin (euchromatin) structure that is transcriptionally active. Deacetylation reverses this process, leading to a closed chromatin structure (heterochromatin) that is generally transcriptionally repressed. Histone deacetylases (HDACs) are enzymes that remove acetyl groups from lysine residues of histone proteins, allowing the histones to condense DNA. HDACs also interact with chromatin through association with other histone-modifying proteins and transcription factors, and they also remove lysine residues from non-histone proteins. Importantly, in proliferating myoblasts, HDAC1-5 and Sirtuins maintain transcription factors in a deacetylated state, particularly when differentiation-promoting signals are absent. Other epigenetic mechanisms such as the expression of specific histone isoforms or the replacement of canonical histones with histone variants can regulate muscle satellite cell quiescence and proliferation (Perdiguero et al. 2009 ).
Epigenetic mechanisms also control the gene expression program during muscle differentiation. In this regard, genes that are actively transcribing are marked by H3K4me3, whereas those ready to be transcribed can be marked by H3K4me2 (Guenther et al. 2007 ). As such, Pax7 was shown to bind to H3K4me2 regulatory elements in target genes such as Myf5 in satellite cells (Kuang et al. 2007; McKinnell et al. 2008) . Interestingly, this binding leads to the recruitment of TRxG histone methyltransferase complex, which in turn will result in elevated H3K4 trimethlyation on the transcription start site (Kuang et al. 2007; McKinnell et al. 2008) . Finally, inactivation of HDACs and Sirtuins together with the concomitant activation of HTAs will allow the activation of transcription factors and nucleosomes for the muscle differentiation program to proceed.
The non-coding microRNAs also play an important role in the control of muscle development. Interestingly, miRNAs are non-coding single-stranded RNA molecules (18-24 nucleotides) that function in the post-transcriptional regulation of gene expression. They exert their action via base-pairing with complementary sequences of mRNA molecules which result in gene silencing via translational repression or target degradation. Importantly, miRNAs may have different mRNA targets, and a given mRNA may also be targeted by multiple miRNAs in a similar fashion. It is well known that miRNAs regulate many cellular processes and have a role in disease pathogenesis, and muscle development. Although microRNAs regulate a wide variety of biological processes in different tissues, tissue-specificity also exists for certain microRNAs. For example, miR-1, miR-133, and miR-206 have been shown to be abundantly expressed in skeletal muscles and they are defined as muscle-specific microRNAs (myomiRs). Several steps of muscle development are tightly regulated by these muscle-specific microRNAs. Despite the potential limitations of the findings reported so far, as a result of the in vitro and/or the use of genetically modified mice, a brief overview on how microRNAs can regulate myogenesis is provided below.
Perinatal lethality, reduced muscle mass, and abnormal myofiber structure has been reported following inactivation of Dicer, which leads to the accumulation of unprocessed pre-miRNAs (O'Rourke et al. 2007 ) thereby pointing to a critical role for myomiRs in skeletal muscle development. The molecules miR-1 and miR-133, which are localized within the same chromosomal locus and are co-transcribed, become two independent mature miRNAs with distinct biological functions in the regulation of skeletal muscle proliferation and differentiation. Interestingly, miR-133 stimulates myoblast proliferation by repressing the serum response factor, and inhibits myotube formation, whereas miR-1 promotes muscle cell differentiation as a result of targeting HDAC4 (Chen et al. 2006) . Similarly to the action of miR-1, miR-206 was reported to promote myotube formation by targeting DNA polymerase alpha (p180 subunit), leading to the inhibition of DNA synthesis and cell cycle withdrawal, as well as to terminal cell differentiation (Deato et al. 2008; Nakajima et al. 2006 ). However, a recent report showed that deletion of miR206/133b resulted in no major defects in developmental and adult myogenesis, or during muscle regeneration (Boettger et al. 2014) . The authors proposed that functional compensation by miR1/133a might explain this surprising lack of a phenotype. In others studies, miR-1 was suggested to target the insulin-like growth factor-1 (IGF-1) pathway, while inducing a feedback loop between miR-1 expression and the IGF-1 signal transduction cascade (Elia et al. 2009 ). Interestingly, downregulation of connexin 43-dependent gap junctional communication by miR-1 and miR-206 also appears to regulate innervation of muscle fibers (Anderson et al. 2006) .
Importantly, other microRNAs ubiquitously expressed in tissues may also play a role in skeletal muscle development. In this context, myoblast differentiation through the downregulation of the paired-box protein Pax7 was reported to be mediated by miR-206 and miR-486 (Dey et al. 2011) . Expression of these two microRNAs favors differentiation in myoblasts, whereas inhibition of their expression results in maintenance of Pax7 activity, which delayed differentiation. In embryonic myotomes, satellite cells, and adult muscle fibers, miR-27 (targets Pax3) is also expressed (Crist et al. 2009 ). Additionally, MyoD was reported to be induced by the action of miR-181, which targets the repressor of myoblast terminal differentiation Hox-A11 (Naguibneva et al. 2006) . The action of miR-29 can favor muscle development through the feedback inhibition of transcriptional repressors such as Yin Yang (YY)1 (Wang et al. 2008) . Notably, loss of miR-29 was also shown to induce the transdifferentiation of myoblasts into myofibroblasts, and transforming growth factor (TGF)-beta signaling negatively regulated its expression (Wang et al. 2012 ). Indeed, miR-29 expression levels decreased in dystrophic muscles from mdx mice (an experimental model of Duchene muscular dystrophy) in the same report (Wang et al. 2012 ). Remarkably, muscle-specific microRNAs were reported to be regulated by the action of muscle-specific transcription factors such as MyoD, Myogenin, myocyte-enhancing factor (MEF)2, and the serum response factor (Rao et al. 2006; Zhao et al. 2005) . Finally, given the wide number of transcriptional targets for miRNAs, more studies are necessary before designing therapeutic strategies in patients with muscle diseases.
Concluding remarks
Epigenetics play a paramount role in the regulation of prenatal and postnatal myogenesis. Future studies will shed light into additional mechanisms that may help understand the process of muscle development and repair following injury. Potential therapeutic strategies will likely emerge once we develop a better understanding of the biological events that underlie myogenesis and muscle repair.
